SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,830.00    135.00 (2.02%)
Bid:
6,825.00
Ask:
6,835.00
Spread: 10.00 (0.147%)
Market Cap: £5.04b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Interim Management Statement

7 Nov 2013 07:00

RNS Number : 4013S
Spirax-Sarco Engineering PLC
07 November 2013
 



 

 

News Release

 

Thursday 7th November 2013

INTERIM MANAGEMENT STATEMENT

 

Strong financial performance against challenging market backdrop

 

Spirax-Sarco Engineering plc, the world leader in the control and efficient use of steam and in peristaltic pumping, issues the following Interim Management Statement in respect of the period from 1st July 2013 to 6th November 2013.

 

Trading

In the four-month period ending 31st October, organic sales were 4% higher than the prior year, as sales growth continued at the same pace as the first half-year. Asia Pacific sales growth was higher in the period, reflecting the benefit of project shipments from orders booked in the first half and continued strong growth in China. Sales grew modestly in each of our EMEA and Americas segments, similar to the rates of growth in the first half. Demand remained soft in North America but the lower sales were more than offset by growth in Latin America. Our Watson-Marlow pumps business faced a particularly difficult comparison due to several large, non-repeating wastewater treatment and mining projects that shipped in the period last year.

 

Recent improvements in global economic conditions have had little overall impact on our markets. Conditions in our mature markets in Europe and North America remain challenging - routine customer maintenance spending has continued stable and resilient but higher value energy saving and plant improvement expenditures are at low levels. Conditions are quite varied in our emerging markets, where we have seen improvement in Southeast Asia and Eastern Europe but recent weakening of conditions in Latin America.

Currency movements have been favourable so far this year, adding less than 2% to sales growth. However, the recent strength of sterling and weakness in some emerging market currencies will, if maintained, erode this favourable currency gain to around 1% for the full year.

 

Our trading performance in the four months ended 31st October 2013 was in line with our expectations. Efficiency improvements in our European manufacturing operations and the cost savings from last year's restructuring in our European sales companies are reflected in higher Group operating margins that remain comfortably ahead of the prior year. As noted previously, our normal seasonal profit bias towards the second half-year was exaggerated in 2012 and we expect that 2013 will revert to a normal first-half/second-half profile.

 

Financial position

Our balance sheet and cash flow remain strong with a net cash balance of £22 million at 31st October 2013, having paid the special dividend of £78 million in July. The interim dividend of 18p per share in respect of 2013, totalling £14 million, will be paid on 8th November 2013. There has been no material change in the financial position of the Group during the period and the principal risks and uncertainties remain as set out on pages 55 to 59 of the 2012 Annual Report. Under new Corporate Governance rules, we are in the process of tendering the Group audit in respect of the period commencing with the 2014 audit and expect to reach a conclusion by the end of this year.

 

Outlook

Our markets tend to broadly mirror general economic activity and rates of industrial production, which we expect to exhibit continued low levels of growth for the balance of this year. Our focus remains on generating our own growth through our strategic priorities of expanding our presence in emerging markets, delivering a broader range of energy saving and plant improvement solutions, and growing market share. Despite sluggish markets and erosion in favourable currency movements, the Board remains confident that the Group will make good progress in 2013.

 

 

Enquiries:

Mark E Vernon, Chief Executive

David Meredith, Director Finance

Tel: 01242 535234

 

Note: References to profit are to adjusted profit that excludes the amortisation of acquisition-related intangible assets, acquisition and disposal costs, and contingent consideration fair value adjustments, together with the tax effects on these items.

 

 

 

 

About Spirax Sarco

Spirax-Sarco Engineering plc is the world leader in both steam system management and peristaltic pumping. The Company provides a broad range of fluid control products, engineered packages, site services and systems expertise for its diverse range of over 100,000 industrial and institutional customers. The Company helps its customers to optimise production capacity, reduce energy costs and emissions, improve product quality and enhance the safety of their operations. Spirax Sarco is headquartered in Cheltenham, England, has strategically located manufacturing plants around the world and employs approximately 4,700 people, of whom around 1,300 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX). Further information can be found at www.spiraxsarcoengineering.com 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBRBDBCDGBGXL
Date   Source Headline
8th Apr 20259:34 amRNSDirector/PDMR Shareholding
8th Apr 20259:32 amRNSNotice of AGM
27th Mar 20254:06 pmRNSDirector/PDMR Shareholding
27th Mar 20254:06 pmRNSDirector/PDMR Shareholding
19th Mar 202511:43 amRNSHolding(s) in Company
12th Mar 20257:00 amRNSDividend Declaration
11th Mar 20257:00 amRNS2024 Full Year Results
10th Mar 20251:42 pmRNSDirector/PDMR Shareholding
10th Feb 20252:23 pmRNSDirector/PDMR Shareholding
31st Jan 20259:00 amRNSBoard Appointment
14th Jan 20253:00 pmRNSDirector/PDMR Shareholding
2nd Jan 20257:00 amRNSBoard Chair Succession
11th Dec 20241:53 pmRNSDirector/PDMR Shareholding
27th Nov 20244:18 pmRNSDirector/PDMR Shareholding
15th Nov 20241:19 pmRNSDirector/PDMR Shareholding
14th Nov 20247:00 amRNSTrading Update
16th Oct 20248:48 amRNSHolding(s) in Company
11th Oct 20241:50 pmRNSDirector/PDMR Shareholding
11th Oct 20247:00 amRNSDirector/PDMR Shareholding
10th Oct 20243:29 pmRNSHolding(s) in Company
3rd Oct 20247:00 amRNSCapital Markets Event
18th Sep 20249:47 amRNSHolding(s) in Company
16th Sep 202410:12 amRNSHolding(s) in Company
13th Sep 202410:57 amRNSHolding(s) in Company
12th Aug 202410:44 amRNSDirector/PDMR Shareholding
8th Aug 20247:00 amRNS2024 Half Year Results
1st Jul 20247:05 amRNSConfirmation of CFO Start Date
5th Jun 20243:46 pmRNSChange of Name
29th May 20248:45 amRNSBoard Succession
15th May 20244:56 pmRNSResult of AGM
15th May 20247:00 amRNSAGM Trading Statement
10th Apr 20244:44 pmRNSDirector/PDMR Shareholding
26th Mar 20249:33 amRNSDirector/PDMR Shareholding
20th Mar 202410:00 amRNSDirector/PDMR Shareholding
18th Mar 20242:34 pmRNSHolding(s) in Company
7th Mar 20247:00 amRNS2023 Full Year Results
22nd Feb 20247:00 amRNSSpirax-Sarco Engineering rebrands as Spirax Group
1st Feb 20243:38 pmRNSChange of Director Details
30th Jan 202411:15 amRNSFuture Board Change
17th Jan 20247:00 amRNSLeadership Succession
18th Dec 20237:00 amRNSChief Financial Officer Appointment
21st Nov 20239:15 amRNSDirector/PDMR Shareholding
20th Nov 20237:00 amRNSDirector/PDMR Shareholding
20th Nov 20237:00 amRNSShare Purchases
16th Nov 20237:00 amRNSTrading Update
11th Oct 20238:40 amRNSDirector/PDMR Shareholding
25th Aug 20239:30 amRNSHolding(s) in Company
25th Aug 20238:30 amRNSHolding(s) in Company
10th Aug 20237:00 amRNS2023 Half Year Results
8th Aug 20237:00 amRNSGroup Chief Executive Succession

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.